Baghaei, P., Dastan, F., Marjani, M., Moniri, A., Abtahian, Z., Ghadimi, S., . . . Tabarsi, P. (2021). Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients. Int Immunopharmacol.
Chicago ZitierstilBaghaei, Parvaneh, et al. "Combination Therapy of IFNβ1 With Lopinavir–ritonavir, Increases Oxygenation, Survival and Discharging of Sever COVID-19 Infected Inpatients." Int Immunopharmacol 2021.
MLA ZitierstilBaghaei, Parvaneh, et al. "Combination Therapy of IFNβ1 With Lopinavir–ritonavir, Increases Oxygenation, Survival and Discharging of Sever COVID-19 Infected Inpatients." Int Immunopharmacol 2021.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.